MiR-125b regulates side population in breast cancer and confers a chemoresistant phenotype

Journal of Cellular Biochemistry

Volumn 114, Issue 10, 2013, Pages 2248-2257

  Wang, Hong Jiang ^a   Guo, Ying Qiu ^b   Tan, Guang ^a   Dong, Lei ^a   Cheng, Lei ^a   Li, Ke Jun ^a   Wang, Zhong Yu ^a   Luo, Hai Feng ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BREAST CANCER; CANCER STEM CELLS; CHEMORESISTANCE; miR 125B; SIDE POPULATION

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; MICRORNA 125B;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CELL; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER STEM CELL; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN TISSUE; MASTECTOMY; PHENOTYPE; POPULATION; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; STEM CELL;

EID: 84882413817     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24574     Document Type: Article

References (39)

1. Bar EE, Lin A, Mahairaki V, Matsui W, Eberhart CG,. 2010. Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Am J Pathol 177: 1491-1502.
2. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C, Croce CM,. 2007. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297: 1901-1908.
3. Bockmeyer CL, Christgen M, Muller M, Fischer S, Ahrens P, Langer F, Kreipe H, Lehmann U,. 2011. MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes. Breast Cancer Res Treat
4. Britton KM, Eyre R, Harvey IJ, Stemke-Hale K, Browell D, Lennard TW, Meeson AP,. 2012. Breast cancer, side population cells and ABCG2 expression. Cancer Lett 323: 97-105.
5. Calcagno AM, Salcido CD, Gillet JP, Wu CP, Fostel JM, Mumau MD, Gottesman MM, Varticovski L, Ambudkar SV,. 2010. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics. J Natl Cancer Inst 102: 1637-1652.
6. Calin GA, Croce CM,. 2006. MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
7. Chen LP, Cai SM, Fan JX, Li ZT,. 1995. PEBA regimen (cisplatin, etoposide, bleomycin, and adriamycin) in the treatment of drug-resistant choriocarcinoma. Gynecol Oncol 56: 231-234.
8. Dean M,. 2009. ABC transporters, drug resistance, and cancer stem cells. Journal of mammary gland biology and neoplasia 14: 3-9.
9. Duan Z, Brakora KA, Seiden MV,. 2004. Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells. Mol Cancer Ther 3: 833-838.
10. Fiebig HH, Maier A, Burger AM,. 2004. Clonogenic assay with established human tumour xenografts: correlation of in vitro to in vivo activity as a basis for anticancer drug discovery. Eur J Cancer 40: 802-820.
11. Fong D, Yeh A, Naftalovich R, Choi TH, Chan MM,. 2010. Curcumin inhibits the side population (SP) phenotype of the rat C6 glioma cell line: towards targeting of cancer stem cells with phytochemicals. Cancer Lett 293: 65-72.
12. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC,. 1996. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183: 1797-1806.
13. Gradishar WJ, Krasnojon D, Cheporov S, Makhson AN, Manikhas GM, Clawson A, Bhar P, McGuire JR, Iglesias J,. 2012. Phase II Trial of Nab-Paclitaxel Compared With Docetaxel as First-Line Chemotherapy in Patients With Metastatic Breast Cancer: Final Analysis of Overall Survival. Clinical breast cancer 12: 313-321.
14. Guo Y, Chen Y, Carreon S, Qiang M,. 2012. Chronic intermittent ethanol exposure and its removal induce a different miRNA expression pattern in primary cortical neuronal cultures. Alcoholism, clinical and experimental research 36: 1058-1066.
15. He M, Guo Q, Hu G,. 2011. Reversed urban-rural differences in breast cancer mortality (China, 2002-2008). Breast Cancer Res Treat 126: 231-234.
16. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM,. 2005. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
17. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ,. 2009. Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
18. Lange C, Yee D,. 2011. Killing the second messenger: targeting loss of cell cycle control inendocrine resistant breast cancer. Endocr Relat Cancer 18: C19-24.
19. Liang Y, Zhong Z, Huang Y, Deng W, Cao J, Tsao G, Liu Q, Pei D, Kang T, Zeng YX,. 2010. Stem-like cancer cells are inducible by increasing genomic instability in cancer cells. J Biol Chem 285: 4931-4940.
20. Liu Z, Liu H, Desai S, Schmitt DC, Zhou M, Khong HT, Klos KS, McClellan S, Fodstad O, Tan M,. 2013. miR-125b Functions as a Key Mediator for Snail-induced Stem Cell Propagation and Chemoresistance. J Biol Chem 288: 4334-4345.
21. Lu D, Chen S, Tan X, Li N, Liu C, Li Z, Liu Z, Stupack DG, Reisfeld RA, Xiang R,. 2012. Fra-1 promotes breast cancer chemosensitivity by driving cancer stem cells from dormancy. Cancer Res 72: 3451-3456.
22. Luo Y, Ellis LZ, Dallaglio K, Takeda M, Robinson WA, Robinson SE, Liu W, Lewis KD, McCarter MD, Gonzalez R, Norris DA, Roop DR, Spritz RA, Ahn NG, Fujita M,. 2012. Side population cells from human melanoma tumors reveal diverse mechanisms for chemoresistance. J Invest Dermatol 132: 2440-2450.
23. Ma L,. 2010. Role of miR-10b in breast cancer metastasis. Breast Cancer Res 12: 210.
24. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA,. 2008. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.
25. Misawa A, Katayama R, Koike S, Tomida A, Watanabe T, Fujita N,. 2010. AP-1-Dependent miR-21 expression contributes to chemoresistance in cancer stem cell-like SP cells. Oncology research 19: 23-33.
26. Ozek NS, Tuna S, Erson-Bensan AE, Severcan F,. 2010. Characterization of microRNA-125b expression in MCF7 breast cancer cells by ATR-FTIR spectroscopy. The Analyst 135: 3094-3102.
27. Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, Packer M, Schneider MD, Levine B,. 2005. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122: 927-939.
28. Shi XB, Xue L, Yang J, Ma AH, Zhao J, Xu M, Tepper CG, Evans CP, Kung HJ, deVere White RW, 2007. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proc Natl Acad Sci U S A 104: 19983-19988.
29. Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, Qian D, Diehn M, Liu H, Panula SP, Chiao E, Dirbas FM, Somlo G, Pera RA, Lao K, Clarke MF,. 2009. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138: 592-603.
30. Singh S, Chitkara D, Mehrazin R, Behrman SW, Wake RW, Mahato RI,. 2012. Chemoresistance in prostate cancer cells is regulated by miRNAs and Hedgehog pathway. PLoS ONE 7: e40021.
31. Tan M, Jing T, Lan KH, Neal CL, Li P, Lee S, Fang D, Nagata Y, Liu J, Arlinghaus R, Hung MC, Yu D,. 2002. Phosphorylation on tyrosine-15 of p34(Cdc2) by ErbB2 inhibits p34(Cdc2) activation and is involved in resistance to taxol-induced apoptosis. Mol Cell 9: 993-1004.
32. Tang F, Zhang R, He Y, Zou M, Guo L, Xi T,. 2012. MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells. PLoS ONE 7: e35435.
33. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG,. 2000. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205-216.
34. Tian S, Huang S, Wu S, Guo W, Li J, He X,. 2010. MicroRNA-1285 inhibits the expression of p53 by directly targeting its 3' untranslated region. Biochem Biophys Res Commun 396: 435-439.
35. Van den Broeck A, Gremeaux L, Topal B, Vankelecom H,. 2012. Human pancreatic adenocarcinoma contains a side population resistant to gemcitabine. BMC Cancer 12: 354.
36. Wang H, Tan G, Dong L, Cheng L, Li K, Wang Z, Luo H,. 2012. Circulating MiR-125b as a marker predicting chemoresistance in breast cancer. PLoS ONE 7: e34210.
37. Xia HF, He TZ, Liu CM, Cui Y, Song PP, Jin XH, Ma X,. 2009. MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf. Cell Physiol Biochem 23: 347-358.
38. Zhang W, Feng M, Zheng G, Chen Y, Wang X, Pen B, Yin J, Yu Y, He Z,. 2012. Chemoresistance to 5-fluorouracil induces epithelial-mesenchymal transition via up-regulation of Snail in MCF7 human breast cancer cells. Biochem Biophys Res Commun 417: 679-685.
39. Zhou M, Liu Z, Zhao Y, Ding Y, Liu H, Xi Y, Xiong W, Li G, Lu J, Fodstad O, Riker AI, Tan M,. 2010. MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J Biol Chem 285: 21496-21507.